Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Number of Participants Being Recruited:
Single / Multi-Center:
STUDY BACKGROUND INFORMATION:
The aim of this project is to find out how useful breath glucose is as a measure of CF lung disease. This study is based upon the finding that glucose levels in the breath of CF patients is raised compared to healthy subjects. The study hopes to show that breath glucose is raised because of lung disease and not other problems found in people with CF.
>= 18 Years
P. aeruginosa status:
B. cepacia status:
Other Primary Eligibility Requirements:
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.